Annual report pursuant to Section 13 and 15(d)

Shareholders' Deficit (Tables)

v3.8.0.1
Shareholders' Deficit (Tables)
12 Months Ended
Dec. 31, 2017
Equity [Abstract]  
Schedule of Preferred Stock

The Company has authorized 5,000,000 shares of preferred stock which have been designated as follows:

 

    Number of Shares     Number of Shares Outstanding     Par     Liquidation  
    Authorized     at December 31, 2017     Value     Value  
Series AA     1,000,000       5,000     $ 0.0001     $ -  
Preferred Series B     50,000       -     $ 0.0001     $ 100  
Preferred Series C     8,000       700     $ 0.0001     $ 1,000  
Undesignated     3,942,000       -       -       -  

Schedule of Stock Options Outstanding

The balance of all stock options outstanding as of December 31, 2017 is as follows:

 

          Weighted Average     Weighted Average        
         

Exercise

Price

   

Remaining

Contractual

   

Aggregate

Intrinsic

 
    Options     Per Share     Term (years)     Value  
Outstanding at January 1, 2017     -     $ -                  
Granted     93,203,369     $ 0.029                  
Cancelled     -     $ -                  
Exercised     -     $ -                  
Outstanding at December 31, 2017     93,203,369     $ 0.029       3.96     $ 2,721,538  
                                 
Exercisable at December 31, 2017     93,203,369     $ 0.029       3.96     $ 2,721,538  

Schedule of Share-based Compensation, Shares Authorized Under Stock Option Plans, by Exercise Price Range

      Outstanding     Exercisable  
            Weighted                    
            Average     Weighted           Weighted  
Range of           Remaining     Average           Average  
Exercise     Number     Contractual     Exercise     Number     Exercise  
Prices     Outstanding     Life     Price     Exercisable     Price  
                                 
Options                                          
                                             
$ 0.0540       19,250,000       9.29     $ 0.0540       19,250,000     $ 0.0540  
$ 0.0269       6,022,305       2.72     $ 0.0269       6,022,305     $ 0.0269  
$ 0.0216       67,931,064       2.55     $ 0.0216       67,931,064     $ 0.0216  
          93,203,369       3.96     $ 0.029       93,203,369     $ 0.029  

Schedule of Warrants Outstanding

A summary of the status of the warrants granted under these agreements at December 31, 2017, and changes during the year then ended is presented below:

 

    Outstanding Warrants  
          Weighted Average  
          Exercise Price  
    Shares     Per Share  
Outstanding at January 1, 2017     9,494,940     $ 0.33  
Granted     52,563,052     $ 0.31  
Cancelled     -     $ -  
Exercised     (250,000 )   $ 0.02  
Outstanding at December 31, 2017     61,807,992     $ 0.31  
                 
Exercisable at December 31, 2017     61,807,992     $ 0.31  

Schedule of Warrants Exercise Price Range

      Outstanding     Exercisable  
            Weighted                    
            Average     Weighted           Weighted  
Range of           Remaining     Average           Average  
Exercise     Number     Contractual     Exercise     Number     Exercise  
Prices     Outstanding     Life     Price     Exercisable     Price  
                                 
Warrants                                          
                                             
$ 0.0165-0.0469       15,019,850       3.44     $ 0.033       15,019,850     $ 0.033  
$ 0.0508-0.10       21,438,396       3.56     $ 0.075       21,438,396     $ 0.075  
$ 0.108-0.239       6,010,037       3.60     $ 0.161       6,010,037     $ 0.161  
$ 0.25-0.48       2,862,687       2.56     $ 0.276       2,862,687     $ 0.276  
$ 0.5623-1.00       16,477,022       2.77     $ 0.938       16,477,022     $ 0.938  
          61,807,992       3.32     $ 0.313       61,807,992     $ 0.313